The JAK2V617F mutation can be found in all three types of Philadelphia-negative MPN, accounting for the vast majority of PV mutations (while a small proportion (1–2%) is due to alternative mutations in the exon 12 of JAK2), and 50–60% in ET or PMF [5,6]. This evidence concerns the gene JAK2 and myeloproliferative disorder.